Sunitinib treatment enabling resection of massive liver metastasis: a case report

INTRODUCTION: Sunitinib was developed as a molecular-targeted drug to treat advanced renal cell carcinoma. It is not yet known whether liver damage occurs in patients with liver metastases of renal cell carcinoma after sunitinib administration. Here, we report the case of a patient with an inoperabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitomo, Shingo, Takahara, Takeshi, Nitta, Hiroyuki, Fujita, Tomohiro, Ito, Naoko, Uesugi, Noriyuki, Sugai, Tamotsu, Wakabayashi, Go
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874753/
https://www.ncbi.nlm.nih.gov/pubmed/24090151
http://dx.doi.org/10.1186/1752-1947-7-234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874753/
https://www.ncbi.nlm.nih.gov/pubmed/24090151
http://dx.doi.org/10.1186/1752-1947-7-234

Ejemplares similares